Atlantic Edge Private Wealth Management »

Redhill Biopharma shares owned by Atlantic Edge Private Wealth Management

Quarter-by-quarter ownership of Redhill Biopharma (RDHL) shares owned by Atlantic Edge Private Wealth Management from 13F filings

Historical chart of Atlantic Edge Private Wealth Management investment in Redhill Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Redhill Biopharma held by Atlantic Edge Private Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Redhill Biopharma by Atlantic Edge Private Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $37 25 1.48

More positions owned by Atlantic Edge Private Wealth Management

Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core Msci Eafe (IEFA)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Msci Emrg Chn (EMXC)
Victory Portfolios Ii Core Intermediat (UITB)
Vaneck Etf Trust Fallen Angel Hg (ANGL)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Microsoft Corporation (MSFT)
Kla Corp Com New (KLAC)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
NVIDIA Corporation (NVDA)

View all positions for Atlantic Edge Private Wealth Management

Top funds holding Redhill Biopharma

Gagnon Securities
Jane Street
Rhumbline Advisers
We Are One Seven
Squarepoint Ops
Aspire Private Capital
Royal Bank of Canada
Steward Partners Investment Advisory
Citigroup
UBS Group
Advisor Group Holdings
Bank of America Corporation
Wells Fargo & Company
Jpmorgan Chase & Co
IFP Advisors

View all funds holding Redhill Biopharma